Treating Renal Anaemia With Recombinant Human Erythropoietin: Practical Guidelines and a Clinical Algorithm.

BMJ
doi 10.1136/bmj.300.6725.655
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Treating Renal Anaemia With Erythropoietin

BMJ
1990English

Non-Cardiac Benefits of Human Recombinant Erythropoietin in End Stage Renal Failure and Anaemia.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1993English

Response of Anaemia in Rheumatoid Arthritis to Treatment With Subcutaneous Recombinant Human Erythropoietin.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1992English

82 Recombinant Human Erythropoietin in the Treatment of Anaemia in Children With End-Stage Renal Failure Maintained by Haemodialysis

Pediatric Research
Child HealthPediatricsPerinatology
1988English

Anaemia and Its Response to Treatment With Recombinant Human Erythropoietin in Chronic Kidney Disease Patients

West African Journal of Medicine
2010English

Treating Anemia Associated With Chronic Renal Failure With Erythropoiesis Stimulators: Recombinant Human Erythropoietin Might Be the Best Among the Available Choices

Medical Hypotheses
Medicine
2012English

Monitoring Erythropoietin Therapy for Anaemia of Chronic Renal Failure by Serum Erythropoietin Assays

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
1993English

Clinical Efficacy and Safety of SB309, a Biosimilar Recombinant Human Erythropoietin, in the Management of Anemia

Biosimilars
2013English

Human Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot Trial

Pediatrics
Child HealthPediatricsPerinatology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy